02.03.2010 • NewsDAK AmericasEastmanlegal

Eastman Sues DAK Americas

Eastman Chemical Company said it has filed a lawsuit against DAK Americas in connection with their unauthorized use of IntegRex PET technology. Eastman developed the technology for the production of PET and said it continues to protect this "technology with a robust patent portfolio." Eastman said it "will vigorously defend these intellectual property assets."

Eastman filed its complaint in the U.S. District Court for the District of Delaware. The complaint alleges patent infringement of three Eastman patents that represent a portion of Eastman's IntegRex technology patent portfolio.

Eastman previously filed a lawsuit against Indorama companies located in the U.S., Europe, and Thailand in connection with their unauthorized use of IntegRex PET technology.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read